A citation-based method for searching scientific literature

V Sossi, D J Doudet, J E Holden. J Cereb Blood Flow Metab 2001
Times Cited: 52







List of co-cited articles
677 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
Vesna Sossi, Raúl de La Fuente-Fernández, James E Holden, Doris J Doudet, Jess McKenzie, A J Stoessl, T J Ruth. J Cereb Blood Flow Metab 2002
88
46


Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase.
J E Holden, D Doudet, C J Endres, G L Chan, K S Morrison, F J Vingerhoets, B J Snow, B D Pate, V Sossi, K R Buckley,[...]. J Nucl Med 1997
46
45

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
C S Lee, A Samii, V Sossi, T J Ruth, M Schulzer, J E Holden, J Wudel, P K Pal, R de la Fuente-Fernandez, D B Calne,[...]. Ann Neurol 2000
365
40

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.
C S Patlak, R G Blasberg, J D Fenstermacher. J Cereb Blood Flow Metab 1983
36

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
D J Doudet, G L Chan, J E Holden, E G McGeer, T A Aigner, R J Wyatt, T J Ruth. Synapse 1998
59
34

Dopa decarboxylase activity of the living human brain.
A Gjedde, J Reith, S Dyve, G Léger, M Guttman, M Diksic, A Evans, H Kuwabara. Proc Natl Acad Sci U S A 1991
137
30

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms.
Vesna Sossi, Raúl de la Fuente-Fernández, James E Holden, Michael Schulzer, Thomas J Ruth, Jon Stoessl. J Cereb Blood Flow Metab 2004
66
30

Nigrostriatal function in humans studied with positron emission tomography.
W R Martin, M R Palmer, C S Patlak, D B Calne. Ann Neurol 1989
281
28

PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Yoshitaka Kumakura, Ingo Vernaleken, Gerhard Gründer, Peter Bartenstein, Albert Gjedde, Paul Cumming. J Cereb Blood Flow Metab 2005
40
37

Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Yoshitaka Kumakura, Albert Gjedde, Erik H Danielsen, Søren Christensen, Paul Cumming. J Cereb Blood Flow Metab 2006
33
45

Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
R de la Fuente-Fernández, J Q Lu, V Sossi, S Jivan, M Schulzer, J E Holden, C S Lee, T J Ruth, D B Calne, A J Stoessl. Ann Neurol 2001
149
25


Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
Raúl de la Fuente-Fernández, Vesna Sossi, Zhigao Huang, Sarah Furtado, Jian-Qiang Lu, Donald B Calne, Thomas J Ruth, A Jon Stoessl. Brain 2004
288
25


Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
S C Huang, D C Yu, J R Barrio, S Grafton, W P Melega, J M Hoffman, N Satyamurthy, J C Mazziotta, M E Phelps. J Cereb Blood Flow Metab 1991
131
23


Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
P Cumming, G C Léger, H Kuwabara, A Gjedde. J Cereb Blood Flow Metab 1993
69
23

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
Vesna Sossi, Raúl de la Fuente-Fernández, Michael Schulzer, Andre R Troiano, Thomas J Ruth, A Jon Stoessl. Ann Neurol 2007
93
23

Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.
Vesna Sossi, Raúl de la Fuente-Fernández, Michael Schulzer, John Adams, Jon Stoessl. Brain 2006
61
21

Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.
Yoshitaka Kumakura, Paul Cumming, Ingo Vernaleken, Hans-Georg Buchholz, Thomas Siessmeier, Andreas Heinz, Thorsten Kienast, Peter Bartenstein, Gerhard Gründer. J Neurosci 2007
97
21

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
J S Rakshi, T Uema, K Ito, D L Bailey, P K Morrish, J Ashburner, A Dagher, I H Jenkins, K J Friston, D J Brooks. Brain 1999
210
19


Loss of metabolites from monkey striatum during PET with FDOPA.
P Cumming, O L Munk, D Doudet. Synapse 2001
17
58

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
K A Frey, R A Koeppe, M R Kilbourn, T M Vander Borght, R L Albin, S Gilman, D E Kuhl. Ann Neurol 1996
238
19

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
B J Snow, I Tooyama, E G McGeer, T Yamada, D B Calne, H Takahashi, H Kimura. Ann Neurol 1993
270
17


Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.
V Kaasinen, E Nurmi, A Brück, O Eskola, J Bergman, O Solin, J O Rinne. Brain 2001
111
17

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.
P Cumming, B E Boyes, W R Martin, M Adam, J Grierson, T Ruth, E G McGeer. J Neurochem 1987
89
17

Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
Ingo Vernaleken, Yoshitaka Kumakura, Paul Cumming, Hans-Georg Buchholz, Thomas Siessmeier, Peter Stoeter, Matthias J Müller, Peter Bartenstein, Gerhard Gründer. Neuroimage 2006
54
17

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
H Hoshi, H Kuwabara, G Léger, P Cumming, M Guttman, A Gjedde. J Cereb Blood Flow Metab 1993
98
15


PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
A R Troiano, R de la Fuente-Fernandez, V Sossi, M Schulzer, E Mak, T J Ruth, A J Stoessl. Neurology 2009
72
15

Distribution volume ratios without blood sampling from graphical analysis of PET data.
J Logan, J S Fowler, N D Volkow, G J Wang, Y S Ding, D L Alexoff. J Cereb Blood Flow Metab 1996
13

Regulation of DOPA decarboxylase activity in brain of living rat.
P Cumming, H Kuwabara, A Ase, A Gjedde. J Neurochem 1995
64
13


Dopamine visualized in the basal ganglia of living man.
E S Garnett, G Firnau, C Nahmias. Nature 1983
436
13

Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease.
Y Kumakura, E H Danielsen, A Reilhac, A Gjedde, P Cumming. Acta Neurol Scand 2004
26
26


Kinetics of the metabolism of four PET radioligands in living minipigs.
N M Gillings, D Bender, L Falborg, K Marthi, O L Munk, P Cumming. Nucl Med Biol 2001
40
17

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.
J Logan, J S Fowler, N D Volkow, A P Wolf, S L Dewey, D J Schlyer, R R MacGregor, R Hitzemann, B Bendriem, S J Gatley. J Cereb Blood Flow Metab 1990
13

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
Stephen McGowan, Andrew D Lawrence, Tim Sales, Digby Quested, Paul Grasby. Arch Gen Psychiatry 2004
149
13

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.
Gerhard Gründer, Ingo Vernaleken, Matthias J Müller, Eugen Davids, Nilufar Heydari, Hans-Georg Buchholz, Peter Bartenstein, Ole L Munk, Peter Stoeter, Dean F Wong,[...]. Neuropsychopharmacology 2003
70
13

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
John R Adams, Hinke van Netten, Michael Schulzer, Edwin Mak, Jessamyn Mckenzie, Audrey Strongosky, Vesna Sossi, Thomas J Ruth, Chong S Lee, Matthew Farrer,[...]. Brain 2005
185
13

Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.
N Pavese, A H Evans, Y F Tai, G Hotton, D J Brooks, A J Lees, P Piccini. Neurology 2006
127
13


Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.
Ruediger Hilker, Katherine Schweitzer, Silke Coburger, Mehran Ghaemi, Simon Weisenbach, Andreas H Jacobs, Jobst Rudolf, Karl Herholz, Wolf-Dieter Heiss. Arch Neurol 2005
188
13

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone, Ray L Watts, A Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E Lang, Olivier Rascol, Maria J Ribeiro, Philippe Remy,[...]. Ann Neurol 2003
587
13

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Andrew H Evans, Nicola Pavese, Andrew D Lawrence, Yen F Tai, Silke Appel, Miroslava Doder, David J Brooks, Andrew J Lees, Paola Piccini. Ann Neurol 2006
274
13

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
T D L Steeves, J Miyasaki, M Zurowski, A E Lang, G Pellecchia, T Van Eimeren, P Rusjan, S Houle, A P Strafella. Brain 2009
334
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.